ArticleThe Journal of clinical and aesthetic dermatology2025
Clinical Age-reversal Quantification of a Facial Skincare Regimen with Sirtuin-targeting Ingredients in a Multiethnic Population.
Article in The Journal of clinical and aesthetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEfficacy evaluations of topical cosmetic products purported to produce younger-appearing skin require an objective assessment of perceived age. The aim of this study is to quantify the age-reversal efficacy of a facial skincare regimen containing sirtuin-targeting and other anti-aging ingredients in a multiethnic population in terms of change in perceived age, using a validated age prediction model.
methodsIn this single-center, monadic study, eligible participants (n=72) applied a 3-product regimen (serum, soft crème, and eye crème) twice daily for 12 weeks. High-resolution digital photographs of subjects were graded for 7 facial parameters using an 11-point photonumeric scale (0=no signs of aging; 10=severe signs of aging) at baseline and 2, 4, 6, 8, and 12 weeks. Predicted Age scores derived from the model algorithm at each assessment point were compared with baseline scores to calculate change in Predicted Age in years.
resultsStatistically significant decreases vs. baseline in calculated Predicted Age were observed as early as Week 2, with the difference increasing with continued product application (difference at Week 12 was -4.0 years). Each facial aging parameter improved at a different rate, with forehead lines and elongated cheek pores significantly improving as early as Week 2. Under eye lines and forehead lines showed the greatest calculated improvement over time.
conclusionBased on the Predicted Age model, the 3-product face/eye skincare regimen applied twice daily resulted in a significant decrease in calculated Predicted Age starting as early as 2 weeks, with continued improvement over time, and a decrease of 4.0 years by Week 12.
Indexed as
Identifiers
41640789PMC12867530What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.